Mice deficient in the inducible nitric-oxide synthase (iNOS), constructed by gene-targeting, were significantly more susceptible to herpes simplex virus (HSV)-1 infection, displayed a delayed clearance of virus from the dorsal root ganglia (DRG) and exhibited an increase in the frequency of virus reactivation in DRG compared with similarly infected heterozygous mice. The infected iNOS-deficient mice developed enhanced Th1-type immune re-
Introduction
Inducible nitric-oxide synthase (iNOS) catalyses the synthesis of high concentrations of nitric oxide (NO) from -arginine and plays a role in microbicidal and tumoricidal activities, and in immunopathology (Moncada & Higgs, 1993 ; Nathan & Xie, 1994) . It may also be important in immune regulation (Albina et al., 1991 ; Liew, 1995) . The role of NO in virus infection is, however, controversial (Croen, 1993 ; Karupiah et al., 1993 ; Burkrinsky et al., 1995 ; Mannick et al., 1994 ; Rolph et al., 1996 ; Adler et al., 1997) . Most of these studies used -arginine analogues which are competitive inhibitors of NO synthases. The discrepancy between the results may be attributable to the non-isoform-selective nature and the variation in the bioavailability of the inhibitors. By gene targeting, we have constructed a mouse strain lacking iNOS (Wei et al., 1995) . These mice are highly susceptible to intracellular parasitic infection. We have now tested the ability of these mice to resist herpes simplex virus (HSV)-1 infection.
Methods
Mice. iNOS-deficient mice were generated as described previously (Wei et al., 1995) . Disruption of the murine iNOS gene was achieved by homologous recombination in 129sv embryonic stem cells. The re- combinant allele was passed through the germ line following mating of embryonic stem cell chimaeras with MF1 (Harlan Olac). The homozygous, heterozygous and wild-type mice thus generated were backcrossed to MF1 for three generations. All the mice used were from matings of littermates and should therefore have had a similar MF1 gene background. Peritoneal cells from mutant mice did not produce iNOS protein following activation by IFN-γ and LPS in vitro as judged by Western blot. They also did not produce detectable amounts of NO following up to 48 h culture with IFN-γ plus LPS. By 72 h, however, a low level of nitrite was detectable in the culture supernatant of cells from mutant mice. This may reflect the accumulation of nitrite produced by constitutive NOS, or the induction of constitutive NOS (Wei et al., 1995) . Female mutant mice and their heterozygous littermates were used at 3-4 weeks old. Extensive previous experiments showed no significant phenotypic difference between the heterozygous and wild-type mice (Wei et al., 1995) ; hence in the present study only heterozygous mice were used as controls.
Virus and infection. HSV-1 (Glasgow strain 17 + ) was grown and titrated in baby hamster kidney cells (BHK21\C13) (MacPherson & Stoker, 1962) propagated in Eagle's medium as described previously (MacLean et al., 1991) . Mice were inoculated in the right hind footpad with the appropriate doses of virus (Robertson et al., 1992) , which were titrated prior to inoculation.
Peripheral virulence. Groups of five mice were inoculated with a series of 10-fold dilutions of virus. Mice were examined daily and the LD &! calculated according to the formula of Reed & Muench (1938) on the basis of the number of deaths up to 42 days post-infection.
Virus replication during acute infection. Mice were inoculated with 10& p.f.u. of virus per mouse. Virus replicates in the footpad, enters 0001-5188 # 1998 SGM ICF the sciatic nerve and travels by retrograde transport to the dorsal root ganglion (DRG) where replication occurs prior to the establishment of a latent infection. Groups of mice were sacrificed at regular intervals and the right rear footpad together with the two lowest thoracic (T11, T12), five lumbar (L1-5) and three sacral (S1-3) DRG were removed from the inoculated side and stored at k70 mC. All ten ganglia from each mouse were pooled, but the footpad and DRG from each mouse were processed separately. Following homogenization and sonication, the virus yield was determined by titration in BHK cells (Robertson et al., 1992) .
Reactivation of latent virus from DRG. Mice were inoculated with 10% or 10& p.f.u. of virus per mouse and examined daily for clinical symptoms. Mice surviving 6 weeks were assayed for the presence of latent virus. The mice were sacrificed and DRG removed from the inoculated side, placed individually in culture medium in microtitre dishes and screened for the release of infectious virus every second day by transferring the culture medium to control BHK cells which were then incubated for 2 days at 37 mC before examining for the presence of virus cytopathic effect.
Antibody titration. Serum (3-5i dilutions) was added into microtitre plates coated with irradiated virus (2i10) p.f.u. equivalent\ ml) and incubated for 1 h. The plates were then washed and antibody detected with peroxidase-conjugated rabbit anti-mouse IgG, IgG1 or IgG2a (Dako) and developed with 2,2h-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid). The plates were read on a Bio-kinetics Reader (Bio-Tek Instrument) at 405 nm. The end-point was calculated as the highest dilution of serum which gave an absorbance reading twice that of the background (with normal mouse serum).
Flow cytometry analysis. Spleen cells were pooled from groups of nine or ten mice and analysed for CD3 + , CD3 + CD4 + and CD3 + CD8 + subsets using the appropriate monoclonal antibody (Becton Dickinson). Labelled cells were analysed by flow cytometry (FACScan, Becton Dickinson).
T cell proliferation. Draining lymph node cells from infected mice were cultured (10' cells\ml) in medium (RPMI 1640, Gibco) containing 0n5 % FCS and 0n5 % normal mouse serum) in flat-bottom 96-well plates (Nunclon) with graded concentrations (5i10"-5i10' p.f.u. equivalent\ml) UV-irradiated HSV-1 for 3-4 days. The cells were then pulsed with [$H]thymidine [1 µCi\well (37 kBq per well), Amersham] for a further 16 h, harvested and the radioactivity counted in a Beta-plate counter (Pharmacia).
Cytokine production and detection. Spleen cells from infected mice were cultured (2i10' cells\ml) in medium (RPMI 1640 and 10 % FCS) in flat-bottom 24-well plates with graded concentrations (10$-10( p.f.u. equivalent\ml) of UV-irradiated virus, or with concanavalin A (ConA) (2n5 µg\ml) or LPS (5 µg\ml) for up to 7 days. Cell-free culture supernatants were collected at 1, 2, 3, 4 and 7 days and cytokine concentrations determined by ELISA in 96-well plates (Immulon 4). IL-12 was captured with a combination of rat monoclonal antibodies to mouse IL-12 P40 (C15.1.2 and C15.6, kind gifts of the Genetic Institute, Cambridge, Mass., USA), and detected with a rabbit anti-mouse IL-12 antibody (Rab.74.6, raised in our laboratory). IFN-γ was captured with a rat monoclonal antibody to mouse IFN-γ (R46AT) and detected with a rabbit anti-mouse IFN-γ antibody. IL-4 was captured with a rat monoclonal anti-IL-4 antibody (TRFK4, PharMingen) and detected with a biotinylated rat anti-mouse IL-4 antibody (BVD6-24G2, PharMingen). ELISA was developed with HRP-conjugated donkey anti-rabbit IgG (SAPU) for IL-12 and IFN-γ, or HRP-conjugated StrepAvidin (SAPU) for IL-4, and followed using TMP HRP substrate (Dynatech, UK). The absorbance was read on a multi-scan (MR5000, Dynatech) at 630 nm. Recombinant cytokines were used as reference standards.
Statistical analysis. Statistical significance (P 0n05) was calculated by the Mann-Whitney test (Minitab software program).
Results and Discussion
iNOS-deficient mice, together with their heterozygous controls, were infected in the footpad with 10-fold dilutions of HSV-1 Glasgow strain 17 + (10$-10' p.f.u. per mouse). Disease development and mortality were monitored for 42 days postinfection. The LD &! of the heterozygotes was 9i10& p.f.u. per mouse, which is comparable to that of normal strain BALB\c mice (Robertson et al., 1992) . This was reduced to 1i10% p.f.u. per mouse in the mutant iNOS-deficient mice. Compared with similarly infected heterozygous control mice, the mutant mice also displayed a significant delay in their ability to clear virus from the footpad and the DRG (Fig. 1 a, b) . iNOS-deficient mice that survived HSV-1 infection of 10%-10& p.f.u. per mouse exhibited a marked increase in the frequency of virus reactivation in the DRG compared with heterozygous mice that had recovered from the same dose of virus ( Fig. 1 c, d ). For ganglia that are not directly supplying the sciatic nerve (T11, T12, L1, L2, S2 and S3) and where virus is spread through the spinal cord, the frequencies of virus reactivation were 85 % for the iNOS-deficient mice and 14 % for heterozygous control mice.
We next investigated the immune response of acutely infected mice. Heterozygous mice infected with 10& p.f.u. of HSV-1 per mouse produced HSV-1-specific antibody detectable 5 days after infection and peaking by day 7. Mutant mice produced significantly higher concentrations of specific antibody from day 5 which progressed through to day 11 (Fig.  2 a) . All the antibody was of the IgG2a isotype ; no IgG1 antibody was detected (data not shown). This is consistent with a previous finding that cellular rather than humoral immunity is required for protection against acute HSV infection (Nash & Wildy, 1983 ; Chan et al., 1985) . During the latent phase of infection by sublethal doses of virus, there was no significant difference between mutant and heterozygous mice in their antibody titre 42 days post-infection (14 000p2133 vs 16 111p3093). Five days after infection with 10& p.f.u. of HSV per mouse, draining lymph node cells were collected and cultured with graded doses of UV-irradiated virus in vitro. Cells from the heterozygous mice produced a modest but significant proliferative response when cultured with 5i10$-5i10% p.f.u.\ml of irradiated virus. This level was markedly elevated in cells from the mutant mice (Fig. 2 b) .
We have previously demonstrated that adoptive transfer of CD4 + T cells primed by glycoprotein B of HSV can protect mice against acute HSV infection (Chan et al., 1985) . Therefore, spleen cells from the infected mice were examined for T cell distribution and cultured with irradiated virus, ConA or LPS in vitro, followed by determination of the concentations of IFN-γ and IL-4 in the culture supernatants. Flow cytometric analysis showed that 40 days after HSV-1 infection, spleen cells (pooled from nine to ten mice per group) from the iNOS-deficient mice Standard errors are shown as vertical bars. Typically, in this type of experiment, due to physical losses, a 100i decline in titre immediately post-infection is observed. Thus the actual virus titre is probably 100i higher than shown. The pattern seen in the heterozygous mice is typical of other normal strains of mouse where virus titre in the footpad peaks on day 2 and declines thereafter, followed by a second peak on day 7 post-infection. No virus was detected by day 14. In the DRG, virus was first detected on day 2, when virus would have travelled up the sciatic nerve, peaked on day 5 following replication in the DRG and thereafter rapidly declined, with no virus detectable by day 14, when a latent infection would have been established. The second peak in the footpad is believed to be due to virus travelling back down the sciatic nerve following replication in the DRG. The time-course of explant reactivation in mice infected with 10 4 (c) or 10 5 (d) p.f.u. of virus per mouse was also examined. Six weeks after inoculation of 4-week-old mice in the right rear footpad, ten DRG were explanted from the right side of surviving mice (four to five mice per group) and assayed every second day for the release of infectious virus in BHK21/C13 cells. The percentage of total DRG reactivating at each time point is shown. Similar results were obtained in two additional experiments.
contained more CD3 + cells (37n9 % vs 31n2%, P 0n05) and CD3 + CD4 + cells (28n7 % vs 20n91 %, P 0n05) but similar fractions of CD3 + CD8 + cells (7n9 % vs 6n98 %) compared with heterozygous mice. Cells from infected iNOS-deficient mutant mice produced significantly more IFN-γ and less IL-4 than those from similarly infected heterozygous control mice (Fig.  3) , indicating a preferential expansion of Th1 cells in the absence of iNOS. These results are consistent with the observation that NO inhibits the development of Th1 cells (Wei et al., 1995 ; Taylor-Robinson et al., 1994) . Cells from mutant mice produced significantly more IL-12 than cells from heterozygous mice at all time points tested (Fig. 4) . Since IL-12 is a major inducer of Th1 cell development (Trinchieri, 1993) and is predominantly produced by macrophages, these data indicate that NO produced endogenously by iNOS in macrophages could inhibit the production of IL-12, thereby limiting the development of Th1 cells. The mechanism by which NO inhibits IL-12 synthesis is at present unclear. However, it is unlikely to be the consequence of higher virus load, since IL-12 is induced rapidly after infection (Kanangat et al., 1996 ; Scott, 1993 ; Ma et al., 1996) and the virus replication rate was similar in both iNOS-deficient and control mice for the first 2 days after infection (Fig. 1 a, b) . Furthermore, a similar phenomenon was observed for Leishmania major infection (unpublished).
Using inhibitors for NO synthase, NO has been shown to inhibit the in vitro replication of ectromelia virus, HSV-1, vaccinia virus, vesicular stomatitis virus and human immunodeficiency virus (Croen, 1993 ; Karupiah et al., 1993 ; Burkrinsky et al., 1995 ; Mannick et al., 1994 ; Bi & Reiss, 1995) . These inhibitors have also been shown to significantly exacerbate ectromelia virus infection (Karupiah et al., 1993) , HSV-1-induced pneumonia (Adler et al., 1997) and influenza virusinduced pneumonia (Akaike et al., 1996) . However, treatment of mice with NOS inhibitors failed to influence the course of vaccina virus (Rolph et al., 1996) , influenza virus (J. P. Tite & F. Y. Liew, unpublished) , or lymphocytic choriomeningitis virus (R. M. Zinkernagel & F. Y. Liew, unpublished) infections. Furthermore, NO appears to protect mice from fatal encephalitis induced by Sindbis virus by a mechanism that does not directly involve the immune response or inhibition of virus growth (Tucker et al., 1996) . The present study provides direct in vivo evidence that iNOS plays a role in inhibiting HSV-1 replication and in host protection. The mechanism by which NO limits virus replication is at present unclear. It is likely that NO acts as a direct effector molecule rather than indirectly through the enhancement of host immune responses because iNOS-deficient mice had reduced resistance to HSV-1 infection in spite of enhanced Th1 response, which is known to be hostprotective against this virus. NO could restrict virus replication by lysing target cells or by direct damage to viral particles as it is generally accepted that macrophage activation is important in determining the outcome of HSV infection, and that resistance correlates with the ability of macrophages to restrict HSV replication and dissemination (Johnson, 1964) . This mechanism predicts that NO is important in infections with macrophages as target cells, but is unlikely to have a major role against virus infections in which CD8 + killer cells are the main effector mechanism. iNOS-deficient mice contain similar levels of CD8 + T cells as heterozygous mice following HSV-1 infection. The ability of iNOS-deficient mice to control low doses of infection indicates that mechanisms in addition to NO are involved in the resistance against HSV-1 infection. Furthermore, macrophages are not the only cell type HSV-1 infects.
A major finding in this report is the preferential induction of Th1 cells in mice deficient in iNOS. This is likely to result from inhibition of IL-12 synthesis by NO. It is now generally agreed that the balance between Th1 (producing IFN-γ) and Th2 (producing IL-4) subsets of CD4 + T cells determines the outcome of many infectious and autoimmune diseases (Sher & Coffman, 1992 ; Liew, 1992 ; Mason & Fowell, 1992) . Our data suggest that iNOS is important in maintaining a state of immunological balance, preventing the overexpansion of Th1 cells which have been implicated in a range of immunopathologies. They also suggest that iNOS inhibitors may be useful adjuvants for vaccination where an enhanced Th1 cell response is essential for protective immunity.
